Jindal, T., Zhang, L., Jiang, C., Kilari, D., Alhalabi, O., Nizam, A., … Koshkin, V. S. (2023). Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Jindal, Tanya, Li Zhang, Cindy Jiang, Deepak Kilari, Omar Alhalabi, Amanda Nizam, Arnab Basu, et al. “Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Jindal T, Zhang L, Jiang C, Kilari D, Alhalabi O, Nizam A, et al. Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Jindal, Tanya, et al. “Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Jindal T, Zhang L, Jiang C, Kilari D, Alhalabi O, Nizam A, Basu A, Bilen MA, Zakharia Y, Milowsky MI, Shah S, Hoimes CJ, Davis NB, Gupta S, Emamekhoo H, Grivas P, Bellmunt J, Campbell MT, Alva AS, Koshkin VS. Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study. JOURNAL OF CLINICAL ONCOLOGY. 2023.